PREVENT Risk Stratification for Intensive Blood Pressure Intervention and Life Expectancy in Rural China: A Post Hoc Analysis of the China Rural Hypertension Control Project
BACKGROUND: The 2025 American Heart Association/American College of Cardiology guideline adopted the Predicting Risk of Cardiovascular Disease Events (PREVENT) equations to guide antihypertensive treatment, but whether PREVENT risk groups identify patients who benefit more from intensive blood pressure (BP) control is uncertain. We evaluated intensive BP control across PREVENT risk groups in the China Rural Hypertension Control Project. METHODS: We analyzed 21 872 hypertensive adults from 326 Chinese villages. Participants received intensive BP control (target <130/80 mm Hg) or usual care and were classified as low risk (<5%), borderline risk (5.0%-7.4%), intermediate risk (7.5%-19.9%), or high risk (≥20%). The primary outcome was a composite of major cardiovascular events (myocardial infarction, stroke, heart failure, or cardiovascular death). Safety, net benefit, and life expectancy were assessed. RESULTS: Over a median of 3.02 years, intensive BP control was associated with lower cardiovascular risk in the low-risk (hazard ratio, 0.53 [95% CI, 0.29-0.97]), intermediate-risk (hazard ratio, 0.58 [95% CI, 0.49-0.69]), and high-risk groups (hazard ratio, 0.60 [95% CI, 0.47-0.77]), but not the borderline-risk group (hazard ratio, 0.80 [95% CI, 0.51-1.26]). No significant treatment-by-risk interaction was observed. Adverse events increased mainly in intermediate- and high-risk groups. Net benefit was favorable across all groups and greatest in the high-risk group. At 45 years of age, estimated life expectancy gains were 0.94 years overall, 0.71 years in the intermediate-risk group, and 1.26 years in the high-risk group. CONCLUSIONS: Intensive BP control was associated with lower cardiovascular risk in 3 PREVENT risk groups, with favorable net benefit across all groups. Absolute benefit and estimated life expectancy gains were greatest among high-risk participants. PREVENT risk stratification may inform intensive BP control in community-based hypertensive populations.
Authors
- Caiyu Zhang (ORCID: https://orcid.org/0000-0002-9416-8650)
- Xiaoqiong Jiang
- Nanxiang Ouyang (ORCID: https://orcid.org/0009-0003-1791-9507)
- 张新刚
- Jiaqi Xu (ORCID: https://orcid.org/0000-0002-4625-4132)
- Wenhang Li (ORCID: https://orcid.org/0009-0009-9854-8851)
- Boquan Wu (ORCID: https://orcid.org/0000-0002-4242-2821)
- Yingxian Sun (ORCID: https://orcid.org/0000-0002-1961-899X)
- Chang Wang (ORCID: https://orcid.org/0000-0002-9410-1878)
- Xiaofan Guo (ORCID: https://orcid.org/0000-0002-7687-0825)
- Yangzhi Yin (ORCID: https://orcid.org/0009-0006-6735-6273)
- Guangxiao Li (ORCID: https://orcid.org/0000-0003-0318-3490)
- Xiangyu Tan (ORCID: https://orcid.org/0009-0007-7565-8498)
- Chenhua He
- Xiaoxuan Tian
- Hongtai Li
- Yifei Chen
- Jie Chen
- Wei Miao
- Ning Ye
Institutions
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Hypertension
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1161/hypertensionaha.126.27624
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00